Fed's Williams: The U.S. economy is in good shape, the job market remains strong. Moderately tight monetary policy provides room for scrutiny of new data.

The Nikkei 225 index opened up 123.04 points, or 0.32%, to 38,913.60 points on June 25 (Wednesday).

Important news 1. The 80th anniversary of the victory of the War of Resistance Against Japanese Aggression will be held on the morning of September 3, including a military review. Xi Jinping will deliver an important speech. 2. Goldman Sachs: China's economic growth is still relatively resilient, and the overweight recommendation for the Chinese stock market is maintained. 3. The central bank: It will study and formulate a new stage of financial technology development plan and issue a policy document to deepen the use of financial technology to promote the digital and intelligent transformation of finance. 4. Han Zheng met with the heads of foreign delegations to the 20th meeting of the secretaries of the Security Council of the Shanghai Cooperation Organization member states. 5. Ministry of Commerce: China firmly opposes the EU's restrictions on Chinese companies and products participating in its public procurement of medical devices. 6. Ministry of Human Resources and Social Security: Individual pensions must pay 3% personal income tax when they are received, without distinguishing between principal and investment income. Stock news 1. The data on the flow of main funds showed that the net inflow of main funds of Oriental Fortune was 1.278 billion yuan, ranking first, while Eastcom Peace, Guoxuan High-tech, Lightwave Technology, and Xiangcai Shares received the largest net inflow of main funds; the net outflow of main funds of Sifang Jingchuang was 914 million yuan, ranking first, while the net outflow of main funds of Zhongji Xuchuang, Zhongyida, Lakala, and AVIC Chengfei ranked first. 2. Dongshan Precision: It is expected that the company's Thai factory will be able to achieve mass production in the second half of the year. 3. Alloy Investment: Guanghui Energy intends to transfer 20.74% of its equity. 4. Borrui Pharmaceuticals released positive data of the dual-target receptor agonist BGM0504 in Phase II. 5. Huabang Health: Fusidic acid cream and fluticasone propionate cream obtained drug registration certificates.